Next Article in Journal
Gadolinium-labeled PLGA Nanoparticles for Magnetic Resonance Imaging
Previous Article in Journal
Influence of Microplate Mixing on Binding Assays
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 77
Issue 6
10.3797/scipharm.oephg.21.SL-23
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Differences in the Glycocalyx of 5637 and SV-HUC-1 Cells and their Impact on Lectin Targeting

by
V. E. PLATTNER
1,*,
F. GABOR
1,
G. BORCHARD
2 and
M. WIRTH
1
1
Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstraße 14, A-1090, Vienna, Austria
2
School of Pharmaceutical Sciences Geneva-Lausanne, University of Geneva, Quai Ernest-Ansermet 30, CH-1211, Geneva, Switzerland
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(6), 190; https://doi.org/10.3797/scipharm.oephg.21.SL-23
Submission received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Versions Notes

Abstract

Background: Bladder cancer is one of the most common malignancies. Advances have been made in diagnosis, therapy, and surveillance resulting in increasing survival rates of patients, but the search for more effective therapies is imperative to be continued. Among others, lectin-mediated targeting might be a promising concept. Thus, the potential of fluorescein-labeled plant lectins was investigated using 5637 cells as a model for human urinary carcinoma [1] and SV-HUC-1 cells as a model for non-tumorigenic human uroepithelial cells.

Share and Cite

MDPI and ACS Style

PLATTNER, V.E.; GABOR, F.; BORCHARD, G.; WIRTH, M. Differences in the Glycocalyx of 5637 and SV-HUC-1 Cells and their Impact on Lectin Targeting. Sci. Pharm. 2009, 77, 190. https://doi.org/10.3797/scipharm.oephg.21.SL-23

AMA Style

PLATTNER VE, GABOR F, BORCHARD G, WIRTH M. Differences in the Glycocalyx of 5637 and SV-HUC-1 Cells and their Impact on Lectin Targeting. Scientia Pharmaceutica. 2009; 77(Short Lectures (SL)):190. https://doi.org/10.3797/scipharm.oephg.21.SL-23

Chicago/Turabian Style

PLATTNER, V. E., F. GABOR, G. BORCHARD, and M. WIRTH. 2009. "Differences in the Glycocalyx of 5637 and SV-HUC-1 Cells and their Impact on Lectin Targeting" Scientia Pharmaceutica 77, Short Lectures (SL): 190. https://doi.org/10.3797/scipharm.oephg.21.SL-23

APA Style

PLATTNER, V. E., GABOR, F., BORCHARD, G., & WIRTH, M. (2009). Differences in the Glycocalyx of 5637 and SV-HUC-1 Cells and their Impact on Lectin Targeting. Scientia Pharmaceutica, 77(Short Lectures (SL)), 190. https://doi.org/10.3797/scipharm.oephg.21.SL-23

Article Metrics

Back to TopTop